Zydus Hospira Oncology Private Limited — Oxaliplatin Exporter Profile
Indian Pharmaceutical Exporter · #9 for Oxaliplatin · $850.0K export value · DGFT Verified
Zydus Hospira Oncology Private Limited is the #9 Indian exporter of Oxaliplatin with $850.0K in export value and 17 verified shipments. Zydus Hospira Oncology Private Limited holds a 1.8% market share in Oxaliplatin exports across 10 countries. The company exports 5 pharmaceutical products worth $4.7M across 2 therapeutic categories.
Zydus Hospira Oncology Private Limited — Oxaliplatin Export Profile: Buyers & Destinations
Where Does Zydus Hospira Oncology Private Limited Export Oxaliplatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| THAILAND | $196.7K | 4 | 32.8% |
| JAPAN | $150.0K | 3 | 25.0% |
| UNITED STATES OF AMERICA | $100.0K | 2 | 16.7% |
| BELGIUM | $50.0K | 1 | 8.3% |
| AUSTRALIA | $34.9K | 1 | 5.8% |
| SINGAPORE | $34.1K | 2 | 5.7% |
| PHILIPPINES | $24.8K | 1 | 4.1% |
| HONG KONG | $9.0K | 1 | 1.5% |
| COSTA RICA | $412 | 1 | 0.1% |
| UNITED KINGDOM | $19 | 1 | 0.0% |
Zydus Hospira Oncology Private Limited exports Oxaliplatin to 10 countries. The largest destination is THAILAND accounting for 32.8% of Zydus Hospira Oncology Private Limited's Oxaliplatin shipments, followed by JAPAN (25.0%) and UNITED STATES OF AMERICA (16.7%). These destinations reflect Zydus Hospira Oncology Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Oxaliplatin from Zydus Hospira Oncology Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| XXIZEXXSERXXCE XXMPAXX BV | BELGIUM | $430.8K | 10 |
| PFIZER SERVICE COMPANY BV | AUSTRALIA | $168.7K | 5 |
| COSTAPHARM SOCIEDAD ANONIMA | COSTA RICA | $412 | 1 |
| XXIZEXXLIMITEDXXDISXXVERXXPARXX | UNITED KINGDOM | $19 | 1 |
Zydus Hospira Oncology Private Limited supplies Oxaliplatin to 4 buyers globally. The largest buyer is XXIZEXXSERXXCE XXMPAXX BV (BELGIUM), followed by PFIZER SERVICE COMPANY BV (AUSTRALIA) and COSTAPHARM SOCIEDAD ANONIMA (COSTA RICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Oxaliplatin Export Value and How Much Does Zydus Hospira Oncology Private Limited Contribute?
India exported $32.6M worth of Oxaliplatin through 3,081 shipments from 249 suppliers to 123 countries, serving 693 buyers globally. Zydus Hospira Oncology Private Limited contributes $850.0K to this total, accounting for 1.8% of India's Oxaliplatin exports. Zydus Hospira Oncology Private Limited ships Oxaliplatin to 10 countries through 4 buyers.
What Is the Average Shipment Value for Zydus Hospira Oncology Private Limited's Oxaliplatin Exports?
Zydus Hospira Oncology Private Limited's average Oxaliplatin shipment value is $50.0K per consignment, based on 17 shipments totaling $850.0K. The largest destination is THAILAND (32.8% of Zydus Hospira Oncology Private Limited's Oxaliplatin exports).
How Does Zydus Hospira Oncology Private Limited Compare to Other Indian Oxaliplatin Exporters?
Zydus Hospira Oncology Private Limited ranks #9 among 249 Indian Oxaliplatin exporters with a 1.8% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($16.6M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($3.6M), ACCURE LABS PRIVATE LIMITED ($2.6M). Zydus Hospira Oncology Private Limited processed 17 shipments to 10 destination countries.
What Oxaliplatin Formulations Does Zydus Hospira Oncology Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| OXALIPLATIN INJ. 100MG US -F000207029 | $100.0K | 2 |
| OXALIPLATIN INJ. 50MG TH -F000041001 | $100.0K | 2 |
| OXALIPLATIN INJ. 100MG TH -F000041172 | $96.7K | 2 |
| OXALIPLATIN INJ.100MG-EG-F000057495 | $50.0K | 1 |
| OXALIPLATIN INJ. 50MG JP (H000015216 | $50.0K | 1 |
| OXALIPLATIN INJ. 200MG JP H000015218 | $50.0K | 1 |
| OXALIPLATIN INJ. 200MG JP (H000015218) | $50.0K | 1 |
| OXALIPLATIN INJ.100MG AU - F000046484 | $34.9K | 1 |
| OXALIPLATIN INJ. 100MG PH F000036304 | $24.8K | 1 |
| OXALIPLATIN INJ. 50MG -SG-F000054120 | $19.1K | 1 |
Zydus Hospira Oncology Private Limited exports 14 distinct Oxaliplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is OXALIPLATIN INJ. 100MG US -F000207029 with 2 shipments worth $100.0K.
Regulatory Requirements: Exporting Oxaliplatin to Key Markets
What Zydus Hospira Oncology Private Limited must comply with to export Oxaliplatin to its top destination countries
Japan — PMDA
Approval Process
Generic Drug Application per Japan Pharmaceutical Affairs Act. Dissolution and bioequivalence studies per PMDA guidelines. Japanese data bridging often required.
Timeline: 12–24 months
GMP & Export Requirements
Japanese GMP (J-GMP); PMDA on-site inspection of Indian manufacturing facility
Foreign Manufacturer Accreditation from PMDA; Japanese MAH (Marketing Authorization Holder) partner required
Note: Japan requires Yen-denominated NHI drug price listing. Stability data under ICH Zone IVb conditions.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Zydus Hospira Oncology Private Limited Compare to Nearest Oxaliplatin Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | VENUS REMEDIES LIMITED | $1.5M | 132 | 14 | $11.3K |
| 5 | GLAND PHARMA LIMITED | $1.0M | 20 | 1 | $50.0K |
| 9 | ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED ★ | $850.0K | 17 | 10 | $50.0K |
| 10 | INTAS PHARMACEUTICALS LIMITED | $790.8K | 32 | 6 | $24.7K |
| 11 | NV REMEDIES PRIVATE LIMITED | $651.6K | 16 | 4 | $40.7K |
Zydus Hospira Oncology Private Limited ranks #9 among 249 Indian Oxaliplatin exporters. Average shipment value of $50.0K compared to the market average of $130.9K. The closest competitors by value are VENUS REMEDIES LIMITED and GLAND PHARMA LIMITED.
Which Indian Ports Ship Oxaliplatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 535 | 17.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 453 | 14.7% |
| DELHI AIR | 436 | 14.2% |
| SAHAR AIR | 410 | 13.3% |
| CHAWAPAYAL ICD (INCPR6) | 110 | 3.6% |
| Bombay Air | 108 | 3.5% |
| NHAVA SHEVA SEA (INNSA1) | 97 | 3.1% |
| CHAWAPAYAL ICD | 95 | 3.1% |
What Other Advanced Oncology Products Does Zydus Hospira Oncology Private Limited Export?
Zydus Hospira Oncology Private Limited also exports these advanced oncology products. Each links to the detailed product page.
About Zydus Hospira Oncology Private Limited
Zydus Hospira Oncology Private Limited exports 5 products worth $4.7M. Beyond Oxaliplatin, top products include Gemcitabine, Irinotecan, Docetaxel, Cytarabine. View the complete Zydus Hospira Oncology Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Oxaliplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Oxaliplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Hospira Oncology Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 17 individual customs records matching Zydus Hospira Oncology Private Limited exporting Oxaliplatin, covering 14 formulations to 10 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 693+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Oxaliplatin Export Data from Zydus Hospira Oncology Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Hospira Oncology Private Limited's Oxaliplatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Hospira Oncology Private Limited
Full Company Profile →
5 products · $4.7M total trade · 2 categories
Oxaliplatin Stats
Company Overview
Top Products by Zydus Hospira Oncology Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Hospira Oncology Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Oxaliplatin. For current shipment-level data, contact TransData Nexus.